Literature DB >> 20350768

Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression.

María Clara Pott Godoy1, Carina Cintia Ferrari, Fernando Juan Pitossi.   

Abstract

Neuroinflammation has been proposed as an important component of Parkinson's Disease (PD) aetiology and/or progression. However, the inflammatory components and the mechanisms underlying their effects are only partially known. By injecting an adenovirus expressing IL-1 in the striatum, we provoked progressive neurodegeneration of dopaminergic cells in the substantia nigra, motor symptoms and microglial activation. All these effects were attenuated by an anti-inflammatory treatment. Interestingly, peripheral inflammatory stimuli exacerbated IL-1beta induced neurodegeneration and the central inflammatory reaction. These data provide evidence that central, chronic IL-1beta expression can trigger and systemic IL-1beta exacerbate nigral neurodegeneration and highlight the functional relevance of this cytokine in PD. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350768     DOI: 10.1016/j.jneuroim.2010.02.018

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

Review 1.  Microglial priming in neurodegenerative disease.

Authors:  V Hugh Perry; Clive Holmes
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

2.  Alteration of Cytokines Levels in the Striatum of Rats: Possible Participation in Vacuous Chewing Movements Induced by Antipsycotics.

Authors:  Luis Ricardo Peroza; Larissa Finger Schaffer; Catiuscia Molz De Freitas; Caroline Queiroz Leal; Mayara Calegaro Ferrari; Marta Maria Frescura Duarte; Roselei Fachinetto
Journal:  Neurochem Res       Date:  2016-05-26       Impact factor: 3.996

3.  Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms.

Authors:  Hossein Sanjari Moghaddam; Zahra Valitabar; Amir Ashraf-Ganjouei; Mahtab Mojtahed Zadeh; Farzaneh Ghazi Sherbaf; Mohammad Hadi Aarabi
Journal:  Neuromolecular Med       Date:  2018-07-06       Impact factor: 3.843

Review 4.  Review of delirium in patients with Parkinson's disease.

Authors:  Emma R L C Vardy; Andrew Teodorczuk; Alison J Yarnall
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

5.  Neurochemical and neuroinflammatory perturbations in two Gulf War Illness models: Modulation by the immunotherapeutic LNFPIII.

Authors:  J M Carpenter; H E Gordon; H D Ludwig; J J Wagner; D A Harn; T Norberg; N M Filipov
Journal:  Neurotoxicology       Date:  2019-12-19       Impact factor: 4.294

6.  Parkinson's disease and systemic inflammation.

Authors:  Carina C Ferrari; Rodolfo Tarelli
Journal:  Parkinsons Dis       Date:  2011-02-22

7.  Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.

Authors:  A Machado; A J Herrera; J L Venero; M Santiago; R M De Pablos; R F Villarán; A M Espinosa-Oliva; S Argüelles; M Sarmiento; M J Delgado-Cortés; R Mauriño; J Cano
Journal:  Parkinsons Dis       Date:  2011-04-13

8.  Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease.

Authors:  Darcy Litteljohn; Emily Mangano; Melanie Clarke; Jessica Bobyn; Kerry Moloney; Shawn Hayley
Journal:  Parkinsons Dis       Date:  2010-12-30

9.  The degenerating substantia nigra as a susceptible region for gene transfer-mediated inflammation.

Authors:  Valeria Roca; Juan Cruz Casabona; Pablo Radice; Verónica Murta; Fernando Juan Pitossi
Journal:  Parkinsons Dis       Date:  2011-05-29

10.  Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?

Authors:  María C Leal; Juan C Casabona; Mariana Puntel; Fernando J Pitossi
Journal:  Front Cell Neurosci       Date:  2013-04-29       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.